PLTR vs CRM: Palantir vs Salesforce — Which AI Software Stock Wins?
Palantir built its reputation in government AI operations — helping intelligence agencies and militaries make faster decisions with complex data. Now it's taking that capability to commercial enterprise. Salesforce defined enterprise CRM for 25 years and is betting Agentforce can extend that lead into the AI agent era. Two different definitions of enterprise AI software, two very different valuations, and two very different risk profiles.
Palantir's AIP Is the Commercial Bet That Changes Its Valuation Story
For most of its history, Palantir was a government contractor that happened to have extraordinary software. Gotham, its government platform, is embedded in US and allied intelligence operations — and it earns high-margin, multi-year contract revenue that's hard to displace. But government revenue grows slowly. The real valuation question is whether Palantir's AI Platform (AIP), launched in 2023 for commercial enterprise, can grow fast enough to justify the premium multiple.
AIP is compelling in demos. It layers Palantir's operational intelligence on top of enterprise data and a customer's choice of large language model, producing a decision-support system that handles complex, multi-source operational problems. The challenge is that Palantir's commercial expansion has been slow relative to the hype — it has strong growth rates but off a small base. At 100x forward earnings, the stock prices in a scenario where AIP becomes the standard enterprise AI operating layer. That's possible; it's not yet probable.
Business Comparison
- Gotham: government/defense AI ops
- AIP: commercial enterprise AI platform
- ~30% government / ~50% commercial revenue mix shift underway
- Growing 25%+ YoY from ~$3B base
- Premium valuation — prices in full enterprise AI adoption
- World's largest CRM platform — 150,000+ customers
- Agentforce: AI agents automating sales/service workflows
- MuleSoft, Tableau, Slack in the platform
- ~35B revenue, ~20% operating margins
- Cheaper valuation but faces agent-driven seat disruption risk
Salesforce Is Cannibalizing Its Own Business — On Purpose
Salesforce's Agentforce is an unusual product: it's designed to automate the manual work that has historically required humans to use Salesforce. A sales agent powered by Agentforce can follow up on leads, update records, and schedule meetings without a human typing it all in. This is intentional self-disruption — Salesforce would rather sell AI agent usage than lose the CRM category to a startup that does it without them.
The transition from per-seat pricing to usage-based pricing (per agent action) is still in early innings. If Agentforce succeeds at scale, Salesforce's revenue model shifts from predictable per-seat subscriptions to variable usage revenue. That transition creates near-term revenue uncertainty but long-term addressable market expansion. Watch how quickly enterprises activate Agentforce agents and how Salesforce reports its consumption metrics.
Who Should Buy Which
Technical Signals — What to Watch
- PLTR volatility: Palantir is extremely sensitive to sentiment shifts around AI. It can rally 15-20% on positive earnings with AIP contract wins and fall sharply on macro risk-off. RSI above 75 after fast rallies is a caution signal; below 40 in bull markets has been an entry opportunity.
- CRM technicals: Salesforce respects its 200-day moving average over multi-year periods. Earnings gaps that hold above the 50-day EMA are continuation signals; gaps that reverse quickly signal caution.
- PLTR key metric: US commercial revenue growth rate and AIP contract wins in each quarterly report. Acceleration above 30% YoY commercial growth re-rates the stock.
- CRM key metric: Agentforce consumption revenue — once this exceeds $500M per quarter, the market will re-rate CRM as a usage-based AI platform rather than a mature seat-based software company.
APEX scores both stocks daily across RSI, MACD, moving averages, volume, and 52-week position. Updated every market day.
Compare PLTR vs CRM Live →